Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies

Hedgehog (Hh) signaling is a well-established developmental pathway; it is crucial for early embryogenesis, cell differentiation, and damage-driven regeneration. It is being increasingly recognized that dysregulated Hh signaling is also involved in fibrotic diseases, which are characterized by exces...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuchen Hu, Linrui Peng, Xinyu Zhuo, Chan Yang, Yuwei Zhang
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/14/12/1485
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846105665462861824
author Yuchen Hu
Linrui Peng
Xinyu Zhuo
Chan Yang
Yuwei Zhang
author_facet Yuchen Hu
Linrui Peng
Xinyu Zhuo
Chan Yang
Yuwei Zhang
author_sort Yuchen Hu
collection DOAJ
description Hedgehog (Hh) signaling is a well-established developmental pathway; it is crucial for early embryogenesis, cell differentiation, and damage-driven regeneration. It is being increasingly recognized that dysregulated Hh signaling is also involved in fibrotic diseases, which are characterized by excessive extracellular matrix deposition that compromises tissue architecture and function. As in-depth insights into the mechanisms of Hh signaling are obtained, its complex involvement in fibrosis is gradually being illuminated. Notably, some Hh-targeted inhibitors are currently under exploration in preclinical and clinical trials as a means to prevent fibrosis progression. In this review, we provide a concise overview of the biological mechanisms involved in Hh signaling. We summarize the latest advances in our understanding of the roles of Hh signaling in fibrogenesis across the liver, kidneys, airways, and lungs, as well as other tissues and organs, with an emphasis on both the shared features and, more critically, the distinct functional variations observed across these tissues and organs. We thus highlight the context dependence of Hh signaling, as well as discuss the current status and the challenges of Hh-targeted therapies for fibrosis.
format Article
id doaj-art-d9cdb5f08f3347f7a9f9728109d80bd4
institution Kabale University
issn 2218-273X
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj-art-d9cdb5f08f3347f7a9f9728109d80bd42024-12-27T14:13:35ZengMDPI AGBiomolecules2218-273X2024-11-011412148510.3390/biom14121485Hedgehog Signaling Pathway in Fibrosis and Targeted TherapiesYuchen Hu0Linrui Peng1Xinyu Zhuo2Chan Yang3Yuwei Zhang4Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, ChinaDivision of Endocrinology and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, ChinaDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, ChinaHedgehog (Hh) signaling is a well-established developmental pathway; it is crucial for early embryogenesis, cell differentiation, and damage-driven regeneration. It is being increasingly recognized that dysregulated Hh signaling is also involved in fibrotic diseases, which are characterized by excessive extracellular matrix deposition that compromises tissue architecture and function. As in-depth insights into the mechanisms of Hh signaling are obtained, its complex involvement in fibrosis is gradually being illuminated. Notably, some Hh-targeted inhibitors are currently under exploration in preclinical and clinical trials as a means to prevent fibrosis progression. In this review, we provide a concise overview of the biological mechanisms involved in Hh signaling. We summarize the latest advances in our understanding of the roles of Hh signaling in fibrogenesis across the liver, kidneys, airways, and lungs, as well as other tissues and organs, with an emphasis on both the shared features and, more critically, the distinct functional variations observed across these tissues and organs. We thus highlight the context dependence of Hh signaling, as well as discuss the current status and the challenges of Hh-targeted therapies for fibrosis.https://www.mdpi.com/2218-273X/14/12/1485hedgehog signaling pathwayfibrosistargeted therapies
spellingShingle Yuchen Hu
Linrui Peng
Xinyu Zhuo
Chan Yang
Yuwei Zhang
Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies
Biomolecules
hedgehog signaling pathway
fibrosis
targeted therapies
title Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies
title_full Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies
title_fullStr Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies
title_full_unstemmed Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies
title_short Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies
title_sort hedgehog signaling pathway in fibrosis and targeted therapies
topic hedgehog signaling pathway
fibrosis
targeted therapies
url https://www.mdpi.com/2218-273X/14/12/1485
work_keys_str_mv AT yuchenhu hedgehogsignalingpathwayinfibrosisandtargetedtherapies
AT linruipeng hedgehogsignalingpathwayinfibrosisandtargetedtherapies
AT xinyuzhuo hedgehogsignalingpathwayinfibrosisandtargetedtherapies
AT chanyang hedgehogsignalingpathwayinfibrosisandtargetedtherapies
AT yuweizhang hedgehogsignalingpathwayinfibrosisandtargetedtherapies